s6y

Escalon Medical Corp

OTC
ESMC
CIK
862668
Industry
Electromedical & Electrotherapeutic Apparatus
Based in
Wayne, Pennsylvania
Incorporated in
Pennsylvania
Fiscal year ends
June 30
SEC filer category
Non-accelerated filer, Smaller reporting company
Employer ID (EIN)
33-0272839

Key figures

Fiscal year to Jun 2026 Jun 2025 Jun 2024 Jun 2023 Jun 2022
Revenue $12.7M$12.0M$12.0M$12.2M$10.7M
Operating income $45.2K$133.2K−$104.5K$478.5K−$470.1K
Net income $4.01M$105.5K−$125.3K$456.8K$18.1K
Diluted EPS $0.27$0.00−$0.02$0.03$0.00
Cash from operations −$402.6K$380.7K−$602.8K$325.1K−$1.05M
Total assets $9.13M$4.99M$4.76M$5.31M$5.17M
Shareholders’ equity $5.93M$1.92M$1.81M$1.93M$1.48M

From the company’s annual reports to the SEC. Each year links to its report.

Financials 154

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-K Annual Report for period ending Jun 30, 2026
  3. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Jun 30, 2026
  4. 10-Q Quarterly Report for period ending Mar 31, 2026
  5. 10-Q Quarterly Report for period ending Dec 31, 2025
  6. 10-Q Quarterly Report for period ending Sep 30, 2025
  7. 10-K Annual Report for period ending Jun 30, 2025
  8. 10-Q Quarterly Report for period ending Mar 31, 2025
  9. 10-Q Quarterly Report for period ending Dec 31, 2024
  10. 10-Q Quarterly Report for period ending Sep 30, 2024

All 154 financials filings

News 79

  1. 8-K Material agreement; Acquisition or sale completed
  2. 8-K Auditor change
  3. 8-K Auditor change
  4. 8-K Material agreement; Material agreement ended; New debt or obligation
  5. 8-K Director or officer change
  6. 8-K Material agreement; Unregistered share sale; Change in control; Charter or bylaw change
  7. 8-K Auditor change
  8. 8-K Director or officer change
  9. 8-K Shareholder vote results
  10. 8-K Material agreement; New debt or obligation

All 79 news filings

Ownership 130

  1. SCHEDULE 13G LPL Financial LLC: Major shareholder report (passive investor)
  2. SCHEDULE 13G/A Major shareholder report (passive investor)
  3. SCHEDULE 13G/A Major shareholder report (passive investor)
  4. SCHEDULE 13G Major shareholder report (passive investor)
  5. SCHEDULE 13G Major shareholder report (passive investor)
  6. SC 13D Major shareholder report
  7. 3 Initial statement of insider ownership
  8. 3 Initial statement of insider ownership
  9. 4 Change in insider ownership
  10. SC 13G/A Major shareholder report (passive investor)

All 130 ownership filings

Prospectus 13

  1. S-3/A Registration statement for specified transactions by certain issuers
  2. S-3 Registration statement for specified transactions by certain issuers
  3. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  4. S-3 Registration statement for specified transactions by certain issuers
  5. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  6. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  7. S-3 Registration statement for specified transactions by certain issuers
  8. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. S-3/A Registration statement for specified transactions by certain issuers

All 13 prospectus filings

Proxies 35

  1. DEF 14A Definitive proxy statements
  2. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  3. DEF 14A Definitive proxy statements
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  6. DEF 14A Definitive proxy statements
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  9. DEF 14A Definitive proxy statements
  10. DEF 14A Definitive proxy statements

All 35 proxies filings

Other 55

  1. ARS Annual report to security holders
  2. 25-NSE Removal from exchange listing
  3. ARS Annual report to security holders
  4. ARS Annual report to security holders
  5. ARS Annual report to security holders
  6. ARS Annual report to security holders
  7. ARS Annual report to security holders
  8. UPLOAD Letter (PDF)
  9. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  10. UPLOAD Letter (PDF)

All 55 other filings

Others in Electromedical & Electrotherapeutic Apparatus

Every company in this industry